Press Releases

Presidential Proclamation—National Alzheimer’s Disease Awareness Month, 2012

November 1, 2012

Every day, families across our country confront the tragic realities of Alzheimer's disease -- an irreversible, fatal illness that robs men and women of their cherished memories and leads to progressive mental and physical impairments. Millions of individuals suffer from this debilitating ailment, and millions more shoulder profound emotional and financial burdens by serving as caregivers for their loved ones.

Lilly Alzheimer’s Drug Trial Results Give Valuable Insight for Future Research

October 8, 2012

USAgainstAlzheimer's Calls on Political, Business, and Civic Leaders to Strengthen Support and Investment in Alzheimer's Research

Leading Alzheimer’s Disease Groups Unveil Monthly Twitter Chat

October 6, 2012

NEW YORK, NY—Several leading groups involved in Alzheimer’s disease or related issues are pioneering a new way of communicating with caregivers of individuals affected by the brain disorder through the development of #TalkAlz, a monthly discussion in the Twittersphere on the second Tuesday of every month at 12 p.m. (ET).

Changing the Trajectory of Alzheimer’s

September 27, 2012

Prepared Remarks of George Vradenburg
Before the National Alzheimer's Advisory Council Inaugural Meeting

I speak today as the Co-Founder and Chairman of USAgainstAlzheimer’s, a national advocacy campaign and network committed to mobilizing the national political will to tackle Alzheimer’s disease. I also serve as the co-convener of Leaders Engaged in Alzheimer’s Disease, a network of over 20 Alzheimer’s-serving organizations serving millions of Americans affected by Alzheimer’s.

Recent Discovery in NIH Funded Study Highlights Need for Renewed Support for Alzheimer’s Research

September 14, 2012

Study found insulin nasal spray may fight memory loss in Alzheimer’s patients

Why 2020?

USAgainstAlzheimer’s has retained its goal of stopping Alzheimer’s by 2020 rather than endorsing the goal of the National Plan to Address Alzheimer’s Disease that calls for preventing and effectively treating the disease by 2025. While we support the national plan and its goals, we believe, as most every family touched by Alzheimer’s disease believes, that preventing and effectively treating Alzheimer's by 2025 is simply too long a wait for concrete progress. There are promising avenues of drug discovery and development that will, if successful, deliver a means of slowing or deferring Alzheimer's symptoms by 2020. By voicing the urgency felt by so many families, we will pressure researchers and industry to do all in their power to make that happen.